Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain.

Blisnick T, Ave P, Huerre M, Carniel E, Demeure CE.

Infect Immun. 2008 Aug;76(8):3808-16. doi: 10.1128/IAI.00034-08. Epub 2008 May 27.

2.

An encapsulated Yersinia pseudotuberculosis is a highly efficient vaccine against pneumonic plague.

Derbise A, Cerdà Marín A, Ave P, Blisnick T, Huerre M, Carniel E, Demeure CE.

PLoS Negl Trop Dis. 2012;6(2):e1528. doi: 10.1371/journal.pntd.0001528. Epub 2012 Feb 14.

3.

Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.

Derbise A, Hanada Y, Khalifé M, Carniel E, Demeure CE.

PLoS Negl Trop Dis. 2015 Oct 16;9(10):e0004162. doi: 10.1371/journal.pntd.0004162. eCollection 2015.

4.

The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis.

Bozue J, Mou S, Moody KL, Cote CK, Trevino S, Fritz D, Worsham P.

Microb Pathog. 2011 Jun;50(6):314-21. doi: 10.1016/j.micpath.2011.02.005. Epub 2011 Feb 12.

PMID:
21320584
5.

A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice.

Bozue J, Cote CK, Webster W, Bassett A, Tobery S, Little S, Swietnicki W.

FEMS Microbiol Lett. 2012 Jul;332(2):113-21. doi: 10.1111/j.1574-6968.2012.02583.x. Epub 2012 May 21.

6.

Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague.

Taylor VL, Titball RW, Oyston PC.

Microbiology. 2005 Jun;151(Pt 6):1919-26.

PMID:
15941999
7.

Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague.

Sha J, Agar SL, Baze WB, Olano JP, Fadl AA, Erova TE, Wang S, Foltz SM, Suarez G, Motin VL, Chauhan S, Klimpel GR, Peterson JW, Chopra AK.

Infect Immun. 2008 Apr;76(4):1390-409. doi: 10.1128/IAI.01529-07. Epub 2008 Jan 28.

8.

[The antibody spectrum after the inoculation of sensitive animals with Yersinia pestis and Yersinia pseudotuberculosis bacteria].

Drobkov VI, Marakulin IV, Pogorel'skiĭ IP, Darmov IV, Smirnov EV.

Zh Mikrobiol Epidemiol Immunobiol. 1996 Mar-Apr;(2):81-5. Russian.

PMID:
8701667
9.

D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague.

Szaba FM, Kummer LW, Wilhelm LB, Lin JS, Parent MA, Montminy-Paquette SW, Lien E, Johnson LL, Smiley ST.

Infect Immun. 2009 Oct;77(10):4295-304. doi: 10.1128/IAI.00273-09. Epub 2009 Jul 20.

10.

Efficacy of an oral live vaccine for veterinary use against pseudotuberculosis.

Quintard B, Petit T, Ruvoen N, Carniel E, Demeure CE.

Comp Immunol Microbiol Infect Dis. 2010 Dec;33(6):e59-65. doi: 10.1016/j.cimid.2009.12.001. Epub 2010 Jan 19.

PMID:
20034670
11.

Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.

Sun W, Roland KL, Kuang X, Branger CG, Curtiss R 3rd.

Infect Immun. 2010 Mar;78(3):1304-13. doi: 10.1128/IAI.01122-09. Epub 2010 Jan 19.

12.

Evolution and virulence contributions of the autotransporter proteins YapJ and YapK of Yersinia pestis CO92 and their homologs in Y. pseudotuberculosis IP32953.

Lenz JD, Temple BR, Miller VL.

Infect Immun. 2012 Oct;80(10):3693-705. doi: 10.1128/IAI.00529-12. Epub 2012 Jul 16.

13.
14.

The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infection.

Okan NA, Mena P, Benach JL, Bliska JB, Karzai AW.

Infect Immun. 2010 Mar;78(3):1284-93. doi: 10.1128/IAI.00976-09. Epub 2010 Jan 11.

15.

LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.

Sun W, Sanapala S, Henderson JC, Sam S, Olinzock J, Trent MS, Curtiss R 3rd.

Infect Immun. 2014 Oct;82(10):4390-404. doi: 10.1128/IAI.02173-14. Epub 2014 Aug 11.

16.

Yersinia pestis caf1 variants and the limits of plague vaccine protection.

Quenee LE, Cornelius CA, Ciletti NA, Elli D, Schneewind O.

Infect Immun. 2008 May;76(5):2025-36. doi: 10.1128/IAI.00105-08. Epub 2008 Mar 17.

17.

Defective innate cell response and lymph node infiltration specify Yersinia pestis infection.

Guinet F, Avé P, Jones L, Huerre M, Carniel E.

PLoS One. 2008 Feb 27;3(2):e1688. doi: 10.1371/journal.pone.0001688.

20.

Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague.

Zauberman A, Tidhar A, Levy Y, Bar-Haim E, Halperin G, Flashner Y, Cohen S, Shafferman A, Mamroud E.

PLoS One. 2009 Jun 16;4(6):e5938. doi: 10.1371/journal.pone.0005938.

Items per page

Supplemental Content

Write to the Help Desk